Record Order Book Masks Domestic Revenue Shift; Execution Risk Ahead

The quarter is a paradox: a headline print that beats and an order book that impresses, shadowed by a single uncomfortable fact. Of ₹1,778 crore in orders, 70% is now domestic—but domestic was only 59% of Q1 revenue. That gap is management's problem, not Lohia's business problem. The company is hedging margins via pre-booked order prices, claiming a 15–20% premium over China still holds. The street bought it halfway. The question is whether six to nine months of execution closes the game or opens it.

Unlike some this season, there is no MTM gain, no tax beat, no exceptional item inflating reported profit. Revenue of ₹503 crore (+60% YoY) and PAT of ₹66.3 crore (+289% YoY) are organic. EBITDA of ₹100 crore sits at 19.9% margin—matching the company's pre-COVID 15–20% band and Q4 FY26 performance. What you see is what happened: capacity utilization at 70–72%, order book hedging domestic mix risk, and operating leverage flowing through. No asterisk.

The PAT jump is steep because Q1 FY26 was compressed (₹17 crore, 2.7% NPM). The 289% YoY is real but not a step-change; it is operating leverage on a recovery base. The number to anchor on is the 13% net profit margin—healthy and stable.

Order book visibility is real. ₹1,778 crore is 3–4 quarters of revenue at 6–9 month execution. At ₹503 crore quarterly run-rate, this book covers H2 FY27 and into FY28. Capex expansion in cement, FIBC, and technical textiles is structural, not cyclical. The single-use plastic ban is a tailwind for at least 3–5 years.

Margins are hedged, not compressed. Management has 2,000 customers globally and only 2–3 known competing suppliers worldwide. The 15–20% premium over China is defensible on service, reliability, and 25 years of export relationships. Pre-booked order prices mean Q1–Q2 domestic revenue is already priced; the risk is Q3–Q4 orders repricing lower.

Replacement cycle is in the early innings. Machines sold in 2002–2003 are now 22–24 years old globally. Currently replacement is only 3–5% of order book; as aging machines fail, this should accelerate. Management is unquantified on this, but it is a multi-year tail upside.

Domestic order concentration could compress margins if repricing stalls. 70% of ₹1,778 crore in orders is domestic (roughly ₹1,245 crore). If customer negotiations push back on prices in Q3–Q4, or if new orders land at lower margin, the 19.9% could drop to 15–17% within two quarters. Management's confidence in pre-booked prices is not quantified.

Export reversion is an assumption, not a plan. The company believes exports will return to 45–55% of revenue, but order book shows only 30%. The gap is roughly ₹530 crore in unbooked export sales (if reversion to 50% is to hold). No timeline, no customer pipeline detail. If geopolitical instability or Chinese competition deepens, this reversion delays and domestic dominance lingers, dragging margins.

Execution risk on 6–9 month cycles is real. Order book visibility is high, but backend-loaded delivery (Q3–Q4 FY27 concentration) means revenue timing concentration. Any supply chain slip, customer capex delay, or credit issue could push deliveries into FY28, flattening H2 FY27 revenue and delaying cash conversion.

Geopolitical and commodity headwinds are acknowledged but uncontrollable. Management cited wars, China supply decisions, and raw material movement as margin headwinds multiple times. If inflation accelerates or supply disruption persists, margins compress despite pre-booked orders (commodity pass-through delays are real).

The market's initial reaction was skeptical: the stock fell 3.82% on day 1 post-announcement, with 49.2% delivery, suggesting retail selling pressure. By day 3, however, sentiment shifted: +4.06% recovery. By day 5, the stock was +6.57% from the announcement close of ₹561.3, pricing in acceptance of the order book bull case. The recovery suggests the market is now betting on execution.

Ownership is dominated by promoters (68.66%), with DII meaningful at 17.52% and FII light at 5.65%. The low FII holding suggests foreign money is cautious; DII strength indicates domestic institutional conviction. Bulk and block deals in the last six months show trading (buys and sells in the ₹487–494 range), with no promoter insider selling near highs—a clean signal.

The recovery from day 1 to day 5 (+6.57%) is the market's own verdict: the order book story is real, execution risk is priced in at current levels, and domestic margin hedging is credible enough to own. The street is not overheated but is comfortable.